Download Files:
MAX-40279 (hemiadipate)
$300 – $2,250
Products Details
Product Description
– MAX-40279 hemiadipate is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 hemiadipate has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1].
Web ID
– HY-145723C
Storage Temperature
– -20°C (Powder, sealed storage, away from moisture)
Shipping
– Blue Ice
Applications
– COVID-19-immunoregulation
Molecular Formula
– C22H23FN6OS.1/2C6H10O4
References
– [1]Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1.
CAS Number
– 2388506-44-1
Molecular Weight
– 584.66
Compound Purity
– 99.26
SMILES
– O=C(O)CCCCC(O)=O.FC1=CC(OC)=C(C2=C(C)SC3=C2N=C(NC4=CN(C5CCNCC5)N=C4)N=C3)C=C1.[1/2]
Clinical Information
– Phase 2
Research Area
– Cancer; Inflammation/Immunology
Solubility
– DMF : 10 mg/mL (ultrasonic;warming;heat to 60°C)|DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– FGFR;FLT3
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
